Baird Medical Investment Holdings Limited
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $37.1M
- Price
- $1.16
- % Change (Daily % change from the live per-ticker quote feed.)
- 0.00%
- Volume
- 26.3K
About
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
Quick stats
Shares outstanding32.0M
Computed float11.0M
Float / shares34.4%
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001982444
Websitehttps://www.bairdmed.com
AI Summary
AI-generated1/14
minorbullishregulatory
Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan
Baird Medical received product registrations from the Drug Regulatory Authority of Pakistan for its BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle.
This regulatory approval builds on the company's existing commercial presence at the Armed Forces Institute of Radiology & Imaging, expanding the foundation for its microwave ablation technology in the region.
The move aligns with Baird Medical's broader international expansion strategy, which has recently seen clinical utilization of its technology in Vietnam and Argentina.